Home Behandelprotocollen PLL Richtlijnen en literatuur

Richtlijnen

Er is op dit moment geen behandelrichtlijn voor PLL.

Literatuur

  1. Cross et al. B en T cell prolymphocytic leukaemia. Best Prac Res clin Haematol 2019;32:217-228
  2. Dearden, C.E. et al. Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. Blood 2011; 118: 5799-5802
  3. Herscher, C. et al. A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive forms. Leuk Lymphoma 2001; 42; 981-7
  4. Matutes, E. et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78; 3269-74
  5. Pawson, R. et al. Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J Clin Oncol 1997; 15; 2667-72
  6. Shvidel, L. et al. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leuk Lymphoma 1999; 33; 169-79

 

Ga terug naar de PLL homepage of lees meer over PLL:

Ga terug naar de algemene homepage Behandelprotocollen.